Quarterly report [Sections 13 or 15(d)]

Investments

v3.25.1
Investments
3 Months Ended
Mar. 29, 2025
Investments, Debt and Equity Securities [Abstract]  
Investments
Note 8 : Investments
Short-term Investments
Short-term investments include marketable debt investments in corporate debt, government debt, and financial institution instruments, and are recorded within cash and cash equivalents and short-term investments on the Consolidated Condensed Balance Sheets. Government debt includes instruments such as non-US government bills and bonds and US agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as fixed- and floating-rate bonds, money market fund deposits, and time deposits. As of March 29, 2025 and December 28, 2024, substantially all time deposits were issued by institutions outside the US.
For certain of our marketable debt investments, we economically hedge market risks at inception with a related derivative instrument or the marketable debt investment itself is used to economically hedge currency exchange rate risk from remeasurement. These hedged investments are reported at fair value with gains or losses from the investments and the related derivative instruments recorded in interest and other, net. The fair value of our economically hedged marketable debt investments was $11.7 billion as of March 29, 2025 ($13.5 billion as of December 28, 2024). For hedged investments still held at the reporting date, we recorded net gains of $190 million in the first three months of 2025 ($307 million of net losses in the first three months of 2024).
Our remaining unhedged marketable debt investments are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss) and realized gains or losses recorded in interest and other, net. The adjusted cost of our unhedged investments was $5.6 billion as of March 29, 2025 ($5.2 billion as of December 28, 2024), which approximated the fair value at these dates.
The fair value of marketable debt investments, by contractual maturity, as of March 29, 2025, was as follows:
(In Millions) Fair Value
Due in 1 year or less
$ 4,146 
Due in 1–2 years
3,056 
Due in 2–5 years
6,063 
Due after 5 years
225 
Instruments not due at a single maturity date1
3,848 
Total $ 17,338 
1 "Instruments not due at a single maturity date" is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.
Equity Investments
(In Millions) Mar 29, 2025 Dec 28, 2024
Marketable equity investments1
$ 541  $ 848 
Non-marketable equity investments
4,486  4,535 
Total $ 5,027  $ 5,383 
1    Most of our marketable equity investments are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. Certain of the trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.
The components of gains (losses) on equity investments, net for each period were as follows:
  Three Months Ended
(In Millions)
Mar 29, 2025 Mar 30, 2024
Unrealized gains (losses) on marketable equity investments $ (292) $ 253 
Unrealized gains (losses) on non-marketable equity investments1
—  24 
Impairment charges (105) (69)
Unrealized gains (losses) on equity investments, net (397) 208 
Realized gains (losses) on sales of equity investments, net 285  (3)
Gains (losses) on equity investments, net $ (112) $ 205 
1 Unrealized gains (losses) on non-marketable investments includes observable price adjustments and our share of equity method investee gains (losses) and certain distributions